Cannell Capital F Star Therapeutics Inc ownership

F Star Therapeutics Inc's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F Star Therapeutics Inc in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.

Cannell Capital ownership history of F Star Therapeutics Inc
ValueSharesWeighting
Q2 2022$111,8040.00%